Christopher Hooper Goss

NPI 1457436289ActiveIndividual· Internal Medicine, Pulmonary Disease· Seattle, WA

Internal Medicine, Pulmonary Disease in Seattle, Washington, trained at University of Colorado School of Medicine, Denver (class of 1992). Their prescriptions cost Medicare Part D more than their services did: $3,771,127 for 505 claims, against $8,551 paid for services in 2024. Boehringer Ingelheim Pharmaceuticals, Inc. reported $562.61 in payments in 2025, mostly travel and lodging.

Overview

NPI	1457436289
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Oct 27, 2006
Last updated in NPPES	Sep 6, 2012

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	MD00034876	WA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (WA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	38
Services billed	98 across 9 procedure codes
Paid by Medicare	$8,551

Part D prescriptions in 2024

Prescriptions (claims)	505 · 729 30-day fills
Patients	54
Total drug cost	$3,771,127

Medicare sources and data years

Education and affiliations

Medical school	University of Colorado School of Medicine, Denver
Graduation year	1992
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists), Internal Medicine
Telehealth	Offers telehealth